STRATA Skin Sciences (NASDAQ:SSKN – Get Free Report) will likely be releasing its earnings data before the market opens on Wednesday, March 26th. Analysts expect STRATA Skin Sciences to post earnings of ($0.40) per share and revenue of $9.03 million for the quarter.
STRATA Skin Sciences Stock Performance
Shares of STRATA Skin Sciences stock opened at $2.68 on Monday. The company has a debt-to-equity ratio of 1.62, a quick ratio of 0.94 and a current ratio of 1.13. STRATA Skin Sciences has a 1 year low of $2.51 and a 1 year high of $5.90. The firm’s 50-day simple moving average is $2.78 and its 200-day simple moving average is $2.93. The firm has a market cap of $11.18 million, a PE ratio of -1.01 and a beta of 1.32.
Wall Street Analysts Forecast Growth
Separately, Maxim Group assumed coverage on STRATA Skin Sciences in a research note on Thursday, February 27th. They set a “buy” rating and a $6.00 price objective on the stock.
STRATA Skin Sciences Company Profile
STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.
Recommended Stories
- Five stocks we like better than STRATA Skin Sciences
- Do ETFs Pay Dividends? What You Need to Know
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 3 ETFs to Ride the VIX Surge During Market Volatility
- What Investors Need to Know to Beat the Market
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
